Background: The usefulness of tumor markers in NSCLC is not well defined. High levels of CEA are considered a negative prognostic factor in early-stages NSCLC but its role in advanced disease is yet ...
Discovery of molecular biomarker signatures for the detection of bladder cancer. This is an ASCO Meeting Abstract from the 2013 Genitourinary Cancers Symposium. This abstract does not include a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback